ES004 is a human monoclonal antibody (mAb) that targets SIRPalpha/CD172a. It enhances macrophage phagocytosis and induces effective T cell responses to promote tumor cell destruction. ES004 is applicable for research in solid tumors.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
